SYN-004 (Ribaxamase), an Oral Beta-Lactamase, Mitigates Antibiotic-Mediated Dysbiosis in a Porcine Gut Microbiome Model

Journal of Applied Microbiology - United Kingdom
doi 10.1111/jam.13432
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Oral Metallo-Beta-Lactamase Protects the Gut Microbiome From Carbapenem-Mediated Damage and Reduces Propagation of Antibiotic Resistance in Pigs

Frontiers in Microbiology
Microbiology
2019English

Gut Microbiome Dysbiosis and Honeybee Health

Journal of Applied Entomology
Insect ScienceAgronomyCrop Science
2011English

Beta-Lactamase Plasmids and Chromosomally Mediated Antibiotic Resistance in Pathogenic Neisseria Species.

Clinical Microbiology Reviews
ImmunologyEnvironmentalPublic HealthMicrobiologyMicrobiology EpidemiologyInfectious DiseasesOccupational Health
1989English

Dysbiosis of Saliva Microbiome in Patients With Oral Lichen Planus

BMC Microbiology
Microbiology
2020English

Protection From Chemotherapy- And Antibiotic-Mediated Dysbiosis of the Gut Microbiota by a Probiotic With Digestive Enzymes Supplement

Oncotarget
Oncology
2018English

Faecalibacterium Prausnitzii Subspecies–level Dysbiosis in the Human Gut Microbiome Underlying Atopic Dermatitis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2016English

Complexities of Gut Microbiome Dysbiosis in the Context of HIV Infection and Antiretroviral Therapy

Clinical Pharmacology and Therapeutics
Pharmacology
2016English

Beta-Lactamase-Mediated Imipenem Resistance in Bacteroides Fragilis.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1986English

Antibiotic Resistance Potential of the Healthy Preterm Infant Gut Microbiome

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy